Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23806 | 3 | 0.06 | Mlig455_006205 | Neo: - Age: Down-Down-Up |
Mlig455_006205 {REF} {Length: 2517} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=21.2]} {RNA1509_46843} {RNA1310_49496} {RNA815_41042} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10770 | 9 | 0.19 | Mlig455_069191 | Neo: - Age: - |
NEFM | 1 | - | - | - | 1.000 | - | - | Mlig455_069191 {REF} {Length: 2284} {Human: ENSG00000104722, NEFM, neurofilament medium, [Score=50.8, Expect=6e-06]} |
2. | MligTC455_23806 | 3 | 0.06 | Mlig455_006205 | Neo: - Age: Down-Down-Up |
1 | - | - | - | 1.000 | - | - | Mlig455_006205 {REF} {Length: 2517} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=21.2]} {RNA1509_46843} {RNA1310_49496} {RNA815_41042} | |
3. | MligTC455_27231 | 12 | 0.25 | Mlig455_013442 | Neo: - Age: - |
SSTR4 | 1 | - | - | - | 1.000 | - | - | Mlig455_013442 {REF} {Length: 1942} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=70.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=63.2, Expect=4e-10]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=72.8, Expect=2e-13]} {Dmel: FBgn0039396, CCAP-R, Crustacean cardioactive peptide receptor, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=50.8, Expect=1e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=123, Expect=1e-31]} {RNA1310_145931} |
4. | MligTC455_34662 | 14 | 0.28 | Mlig455_026025 | Neo: - Age: - |
FOXG1 | 1 | - | - | - | 1.000 | - | - | Mlig455_026025 {REF} {Length: 2940} {Pfam: Forkhead domain [PF00250.20, score=130.9]} {Human: ENSG00000176165, FOXG1, forkhead box G1, [RH, Score=206, Expect=3e-60]} {Mouse: ENSMUSG00000020950, Foxg1, forkhead box G1, [RH, Score=206, Expect=9e-61]} {Dmel: FBgn0004567, slp2, sloppy paired 2, [RH, Score=215, Expect=1e-64]} {Celegans: WBGene00001434, fkh-2, ForKHead transcription factor family, [RH, Score=186, Expect=9e-56]} {Smed: dd_Smed_v6_16466_0_1, dd_Smed_v6_16466_0_1, [RH, Score=164, Expect=1e-48]} {RNA1509_39072} {RNA1310_98689} {RNA815_51347} |
5. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 0.996 | - | - | - | 0.996 | - | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
6. | MligTC455_02622 | 18 | 0.38 | Mlig455_034646, Mlig455_062629 | Neo: - Age: - |
CACNG5 | 0.995 | - | - | - | 0.995 | - | - | Mlig455_034646 {REF} {Length: 1447} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} Mlig455_062629 {REF} {Length: 1628} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} |
7. | MligTC455_09917 | 32 | 0.67 | Mlig455_044172 | Neo: - Age: - |
SLC24A3 | 0.994 | - | - | - | 0.994 | - | - | Mlig455_044172 {REF} {Length: 2760} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=165.1]} {Human: ENSG00000185052, SLC24A3, solute carrier family 24 member 3, [Score=273, Expect=3e-82]; ENSG00000155886, SLC24A2, solute carrier family 24 member 2, [Score=262, Expect=3e-78]} {Mouse: ENSMUSG00000037996, Slc24a2, solute carrier family 24 (sodium/potassium/calcium exchanger), member 2, [Score=270, Expect=6e-81]; ENSMUSG00000063873, Slc24a3, solute carrier family 24 (sodium/potassium/calcium exchanger), member 3, [Score=268, Expect=6e-81]} {Dmel: FBgn0028704, Nckx30C, [Score=248, Expect=1e-71]} {Celegans: WBGene00003569, ncx-4, Na/Ca eXchangers, [Score=142, Expect=7e-36]} {Smed: dd_Smed_v6_9736_0_1, dd_Smed_v6_9736_0_1, [Score=285, Expect=7e-88]} {RNA1310_23810} {RNA815_17580} |
8. | MligTC455_29618 | 4 | 0.09 | Mlig455_062489 | Neo: - Age: - |
0.99 | - | - | - | 0.990 | - | - | Mlig455_062489 {REF} {Length: 1382} {NoTransDecoderORF} {RNA1310_81883} | |
9. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
0.987 | - | - | - | 0.987 | - | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
10. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 0.984 | - | - | - | 0.984 | - | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
11. | MligTC455_22125 | 178 | 3.71 | Mlig455_028579, Mlig455_028597 | Neo: - Age: - Region-enriched R2: 5.949/0.00261 |
0.983 | - | - | - | 0.983 | - | - | Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} |
|
12. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
0.98 | - | - | - | 0.980 | - | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
13. | MligTC455_00984 | 6 | 0.13 | Mlig455_027441 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_027441 {REF} {Length: 318} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_58713} {RNA1310_116650} {RNA815_27019} | |
14. | MligTC455_01861 | 30 | 0.63 | Mlig455_046027 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_046027 {REF} {Length: 736} {RNA1310_50531} {RNA815_29422} | |
15. | MligTC455_10840 | 7 | 0.15 | Mlig455_002922 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_002922 {REF} {Length: 931} {RNA1310_87221} {RNA815_45993} | |
16. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_045246 {REF} {Length: 719} | |
17. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
18. | MligTC455_20335 | 30 | 0.62 | Mlig455_003579 | Neo: - Age: - |
0.979 | - | - | - | 0.979 | - | - | Mlig455_003579 {REF} {Length: 3608} {RNA1310_50785} {RNA815_44116} | |
19. | MligTC455_21415 | 38 | 0.78 | Mlig455_030394, Mlig455_069019 | Neo: - Age: Up-Down-Down |
SCN5A | 0.979 | - | - | - | 0.979 | - | - | Mlig455_030394 {REF} {Length: 6394} {Pfam: Ion transport protein [PF00520.33, score=542.0]; Polycystin cation channel [PF08016.14, score=81.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=26.0]} {Human: ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [RH, Score=944, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [RH, Score=942, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [RH, Score=932, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [RH, Score=924, Expect=0.0]} {Dmel: FBgn0085434, NaCP60E, Na channel protein 60E, [RH, Score=896, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=322, Expect=2e-90]} {Smed: dd_Smed_v6_12243_0_1, dd_Smed_v6_12243_0_1, [Score=1238, Expect=0.0]} {RNA1509_26911} {RNA1310_25124} {RNA815_23541} Mlig455_069019 {REF} {Length: 6623} {Pfam: Ion transport protein [PF00520.33, score=774.7]; Polycystin cation channel [PF08016.14, score=76.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=25.2]} {Human: ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [RH, Score=1268, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [RH, Score=1214, Expect=0.0]} {Mouse: ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [RH, Score=1276, Expect=0.0]} {Dmel: FBgn0085434, NaCP60E, Na channel protein 60E, [RH, Score=899, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=322, Expect=9e-89]} {Smed: dd_Smed_v6_12243_0_1, dd_Smed_v6_12243_0_1, [Score=1233, Expect=0.0]} {RNA1509_26911} {RNA1310_25124} {RNA815_23541} |
20. | MligTC455_43085 | 7 | 0.14 | Mlig455_035380 | Neo: - Age: - Region-enriched R4: 3.349/0.01204 |
0.979 | - | - | - | 0.979 | - | - | Mlig455_035380 {REF} {Length: 1093} {Pfam: Lectin C-type domain [PF00059.23, score=30.6]} {RNA1509_45080} {RNA1310_133134} | |
21. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
22. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 0.978 | - | - | - | 0.978 | - | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
23. | MligTC455_38838 | 24 | 0.49 | Mlig455_033571, Mlig455_067059 | Neo: - Age: - |
0.978 | - | - | - | 0.978 | - | - | Mlig455_033571 {REF} {Length: 1596} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} Mlig455_067059 {REF} {Length: 1559} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} |
|
24. | MligTC455_41721 | 1545 | 32.19 | Mlig455_000238 | Neo: - Age: logFC(26M/2M)=1.827 Region-enriched R2: 7.263/0.00002 |
0.978 | - | - | - | 0.978 | - | - | Mlig455_000238 {REF} {Length: 600} {RNA1509_17403} {RNA1310_82552.1} {RNA815_43140.1} | |
25. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
0.978 | - | - | - | 0.978 | - | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
26. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
0.977 | - | - | - | 0.977 | - | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
27. | MligTC455_14123 | 49 | 1.01 | Mlig455_004226, Mlig455_031058 | Neo: - |
MUC17 | 0.976 | - | - | - | 0.976 | - | - | Mlig455_004226 {REF} {Length: 15360} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=143.9]; Thrombospondin type 1 domain [PF00090.21, score=83.9]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]} {Human: ENSG00000169876, MUC17, mucin 17, cell surface associated, [Score=86.7, Expect=8e-16]; ENSG00000143341, HMCN1, hemicentin 1, [Score=85.5, Expect=2e-15]} {Mouse: ENSMUSG00000099398, Ms4a14, membrane-spanning 4-domains, subfamily A, member 14, [Score=94.4, Expect=2e-18]} {Dmel: FBgn0026721, fat-spondin, [Score=55.1, Expect=1e-06]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=72.8, Expect=4e-12]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [RH, Score=419, Expect=8e-124]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} Mlig455_031058 {REF} {Length: 19314} {Human: ENSG00000169876, MUC17, mucin 17, cell surface associated, [Score=81.3, Expect=4e-14]} {RNA1509_11979, RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612} {RNA1310_16813.1, RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612} {RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612, RNA815_1331} |
28. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 0.972 | - | - | - | 0.972 | - | - | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
29. | MligTC455_28116 | 36 | 0.74 | Mlig455_023222, Mlig455_068295 | Neo: - Age: Down-Down-Up |
0.972 | - | - | - | 0.972 | - | - | Mlig455_023222 {REF} {Length: 2305} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1} {RNA815_17069.1} Mlig455_068295 {REF} {Length: 1692} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1} {RNA815_17069.1} |
|
30. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 0.971 | - | - | - | 0.971 | - | - | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
31. | MligTC455_02495 | 2759 | 57.47 | Mlig455_039292 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.530/0.00442 |
0.969 | - | - | - | 0.969 | - | - | Mlig455_039292 {REF} {Length: 910} {RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1310_15694.2, RNA1509_35923, RNA1509_4995, RNA1509_7740} {RNA1509_35923, RNA1509_4995, RNA1509_7740, RNA815_5222} | |
32. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
0.969 | - | - | - | 0.969 | - | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
33. | MligTC455_02494 | 237 | 4.93 | Mlig455_004106 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.703/0.00228 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_004106 {REF} {Length: 917} {RNA1509_21522, RNA1509_4995} {RNA1310_15694.2, RNA1509_21522} {RNA1509_21522, RNA815_5222} | |
34. | MligTC455_46285 | 568 | 11.84 | Mlig455_063390 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 4.933/0.00026 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_063390 {REF} {Length: 871} {RNA1509_48573} {RNA1310_59611, RNA1509_48573} {RNA1509_48573, RNA815_35731} | |
35. | MligTC455_46903 | 255 | 5.3 | Mlig455_040553 | Neo: - Age: - Region-enriched R2: 9.597/0.00026 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_040553 {REF} {Length: 562} {RNA1509_45949} {RNA1310_70304, RNA1509_45949} {RNA1509_45949, RNA815_37653} | |
36. | MligTC455_53468 | 14 | 0.28 | Mlig455_070377 | Neo: - Age: - |
0.968 | - | - | - | 0.968 | - | - | Mlig455_070377 {REF} {Length: 2927} {Pfam: Glycine rich protein [PF12810.9, score=23.6]} {RNA1509_10020} {RNA1310_33363.2} {RNA815_25152} | |
37. | MligTC455_11713 | 8 | 0.16 | Mlig455_030060 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_030060 {REF} {Length: 1189} {RNA1310_40798} {RNA815_26160} | |
38. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 0.967 | - | - | - | 0.967 | - | - | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
39. | MligTC455_48306 | 2324 | 48.41 | Mlig455_015219, Mlig455_027177 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.663 Region-enriched R2: 5.798/0.00022 |
0.967 | - | - | - | 0.967 | - | - | Mlig455_015219 {REF} {Length: 741} {RNA1509_16577, RNA1509_18537} {RNA1310_58052, RNA1509_16577, RNA1509_18537} {RNA1509_16577, RNA1509_18537, RNA815_31153} Mlig455_027177 {REF} {Length: 870} {RNA1509_16577} {RNA1310_58052} {RNA815_31153} |
|
40. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 0.966 | - | - | - | 0.966 | - | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
41. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
0.966 | - | - | - | 0.966 | - | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
42. | MligTC455_17612 | 38 | 0.78 | Mlig455_057835 | Neo: - Age: - |
ADRB2 | 0.965 | - | - | - | 0.965 | - | - | Mlig455_057835 {REF} {Length: 2257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=166.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.1]} {Human: ENSG00000169252, ADRB2, adrenoceptor beta 2, [Score=118, Expect=1e-28]} {Mouse: ENSMUSG00000045730, Adrb2, adrenergic receptor, beta 2, [Score=118, Expect=6e-29]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=129, Expect=4e-32]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=116, Expect=2e-28]} {Smed: dd_Smed_v6_15854_0_1, dd_Smed_v6_15854_0_1, [RH, Score=229, Expect=1e-70]} {RNA1310_66275} {RNA815_49974} |
43. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 0.964 | - | - | - | 0.964 | - | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
44. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 0.963 | - | - | - | 0.963 | - | - | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
45. | MligTC455_02258 | 14 | 0.29 | Mlig455_004819, Mlig455_004888, Mlig455_004900 | Neo: - Age: - |
SLC9B2 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_004819 {REF} {Length: 2596} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=54.1]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=125, Expect=5e-31]; ENSG00000164037, SLC9B1, solute carrier family 9 member B1, [Score=119, Expect=4e-29]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=128, Expect=4e-32]; ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=128, Expect=3e-32]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=115, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=52.8, Expect=3e-07]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=126, Expect=1e-33]} {RNA1310_33802} Mlig455_004888 {REF} {Length: 2402} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=5e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=6e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=1e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=138, Expect=3e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=1e-116]} {RNA1310_33802} Mlig455_004900 {REF} {Length: 3013} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=115.6]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=325, Expect=6e-102]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=326, Expect=5e-102]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [RH, Score=289, Expect=2e-86]} {Celegans: WBGene00009618, F41E7.2, [Score=139, Expect=2e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=361, Expect=2e-116]} {RNA1509_37253} {RNA1310_95649} {RNA815_29346.1} |
46. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
0.962 | - | - | - | 0.962 | - | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
47. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
48. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
49. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 0.961 | - | - | - | 0.961 | - | - | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
50. | MligTC455_51763 | 1421 | 29.6 | Mlig455_015843 | Neo: - Age: - Region-specific R2: 3.066 Region-enriched R2: 2.560/0.00003 |
0.96 | - | - | - | 0.960 | - | - | Mlig455_015843 {REF} {Length: 805} {RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1310_60107.2, RNA1509_26419, RNA1509_39553, RNA1509_39658} {RNA1509_26419, RNA1509_39553, RNA1509_39658, RNA815_31573} | |
51. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 0.959 | - | - | - | 0.959 | - | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
52. | MligTC455_35561 | 23 | 0.47 | Mlig455_058398 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_058398 {REF} {Length: 576} {NoTransDecoderORF} | |
53. | MligTC455_27334 | 8215 | 171.14 | Mlig455_016712, Mlig455_029695, Mlig455_054619 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.862/0.00000 Regeneration-downregulated R2: -6.166 Regeneration-depleted R2: -6.166 |
GNAI1 | 0.958 | - | - | - | 0.958 | - | - | Mlig455_016712 {REF} {Length: 1973} {Pfam: G-protein alpha subunit [PF00503.22, score=406.7]; ADP-ribosylation factor family [PF00025.23, score=55.8]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.9]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.7]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=484, Expect=3e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=477, Expect=1e-168]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=473, Expect=4e-167]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=484, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=480, Expect=4e-170]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=471, Expect=2e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=469, Expect=1e-165]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=439, Expect=6e-154]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=593, Expect=0.0]} {RNA1509_45426} {RNA1310_25155} {RNA815_14897.2} Mlig455_029695 {REF} {Length: 555} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_2874, RNA1509_3945, RNA1509_46274} {RNA1310_102625.1, RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274} {RNA1509_10588, RNA1509_1324, RNA1509_2721, RNA1509_3945, RNA1509_46274, RNA815_20834} Mlig455_054619 {REF} {Length: 911} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=36.2]} {RNA1509_40708} {RNA1310_26224} {RNA815_14744.1} |
54. | MligTC455_31333 | 577 | 12.03 | Mlig455_015221 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.948/0.00003 |
0.958 | - | - | - | 0.958 | - | - | Mlig455_015221 {REF} {Length: 722} {RNA1509_15363, RNA1509_24781} {RNA1310_37267, RNA1509_15363, RNA1509_24781} {RNA1509_15363, RNA1509_24781, RNA815_31275} | |
55. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
0.958 | - | - | - | 0.958 | - | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
56. | MligTC455_44030 | 257 | 5.36 | Mlig455_035454 | Neo: - Age: Down-Up-Down |
0.958 | - | - | - | 0.958 | - | - | Mlig455_035454 {REF} {Length: 2210} {Pfam: Lectin C-type domain [PF00059.23, score=25.6]} {RNA1509_32990} {RNA1310_18199, RNA1509_32990} {RNA1509_32990, RNA815_7340} | |
57. | MligTC455_12105 | 21 | 0.43 | Mlig455_015631 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_015631 {REF} {Length: 1685} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=22.5]} {Smed: dd_Smed_v6_13742_0_1, dd_Smed_v6_13742_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_95837} | |
58. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
59. | MligTC455_19819 | 67 | 1.39 | Mlig455_042327, Mlig455_047107 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_042327 {REF} {Length: 1414} {RNA1310_83687} Mlig455_047107 {REF} {Length: 1283} {RNA1310_83687} |
|
60. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
0.956 | - | - | - | 0.956 | - | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
61. | MligTC455_47741 | 102 | 2.13 | Mlig455_004211 | Neo: - Age: Down-Up-Up |
0.955 | - | - | - | 0.955 | - | - | Mlig455_004211 {REF} {Length: 1794} {RNA1310_23101} {RNA815_45601} | |
62. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 0.954 | - | - | - | 0.954 | - | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
63. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
0.954 | - | - | - | 0.954 | - | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
64. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
65. | MligTC455_45682 | 167 | 3.49 | Mlig455_065509 | Neo: - Age: - |
0.953 | - | - | - | 0.953 | - | - | Mlig455_065509 {REF} {Length: 811} {Pfam: Late nodulin protein [PF07127.13, score=20.4]} {RNA1310_45419} {RNA815_22274} | |
66. | MligTC455_16471 | 45 | 0.94 | Mlig455_042944 | Neo: - Age: - |
NKX2-3 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_042944 {REF} {Length: 1426} {Pfam: Homeodomain [PF00046.31, score=67.5]} {Human: ENSG00000119919, NKX2-3, NK2 homeobox 3, [RH, Score=122, Expect=1e-31]} {Mouse: ENSMUSG00000044220, Nkx2-3, NK2 homeobox 3, [RH, Score=122, Expect=2e-31]} {Dmel: FBgn0028993, scro, scarecrow, [Score=106, Expect=3e-26]} {Celegans: WBGene00000450, ceh-28, C. Elegans Homeobox; NK-2 family homeodomain protein CEH-28, [RH, Score=97.8, Expect=4e-24]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [Score=109, Expect=3e-27]} {RNA1310_91075} |
67. | MligTC455_33099 | 20 | 0.42 | Mlig455_023705 | Neo: - Age: - |
0.952 | - | - | - | 0.952 | - | - | Mlig455_023705 {REF} {Length: 1888} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35225} {RNA1310_19456} {RNA815_41929} | |
68. | MligTC455_33239 | 57 | 1.18 | Mlig455_006962 | Neo: - Age: - |
CACNG5 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_006962 {REF} {Length: 1957} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=72.5]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=60.2]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=91.3, Expect=5e-20]; ENSG00000105605, CACNG7, calcium voltage-gated channel auxiliary subunit gamma 7, [Score=89.0, Expect=4e-19]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=90.1, Expect=9e-20]; ENSMUSG00000069806, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]; ENSMUSG00000096998, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]} {Dmel: FBgn0064123, stg1, stargazin-like protein, [Score=62.0, Expect=6e-10]} {Smed: dd_Smed_v6_20066_0_1, dd_Smed_v6_20066_0_1, [RH, Score=228, Expect=2e-68]} {RNA1310_39723} {RNA815_37605} |
69. | MligTC455_34208 | 91 | 1.89 | Mlig455_059233 | Neo: - Age: - |
TBX1 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_059233 {REF} {Length: 1822} {Pfam: T-box [PF00907.24, score=245.5]} {Human: ENSG00000184058, TBX1, T-box 1, [RH, Score=293, Expect=2e-92]} {Mouse: ENSMUSG00000009097, Tbx1, T-box 1, [RH, Score=296, Expect=5e-94]; ENSMUSG00000037477, Tbx10, T-box 10, [RH, Score=284, Expect=2e-90]} {Dmel: FBgn0021767, org-1, optomotor-blind-related-gene-1, [RH, Score=296, Expect=1e-91]} {Celegans: WBGene00003376, mls-1, T-box transcription factor mls-1, [RH, Score=230, Expect=6e-72]} {Smed: dd_Smed_v6_26182_0_1, dd_Smed_v6_26182_0_1, [RH, Score=245, Expect=1e-76]} {RNA1310_21326.1} {RNA815_34019} |
70. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |